Results 171 to 180 of about 27,171 (223)
Some of the next articles are maybe not open access.

Report on Oral Polio Vaccines

JAMA: The Journal of the American Medical Association, 1965
To the Editor:— In your issue of Oct 5, 1964 (Vol 190), you published a report of the Surgeon General's Special Advisory Committee on "Oral Poliomyelitis Vaccines" together with a commentary by Dr. Albert Sabin. While both of these are valuable documents, both contain statements and points of view that should not go unchallenged. The Committee report,
G W, ANDERSON, D A, HENDERSON
openaire   +2 more sources

Sero-conversion after oral polio vaccine

The Indian Journal of Pediatrics, 1978
Seventy eight paired sera were studied for sero-conversion after oral polio vaccine, in children belonging to the age group 3 months to 3 years. Sero-conversion was highest i.e. 92 3 percent for polio virus 2, 83.3 percent for polio virus 3 and 57.6 per cent for polio virus.
U D, Hardas   +2 more
openaire   +2 more sources

SEROLOGIC RESPONSE TO ORAL POLIO VACCINE AND ENHANCED-POTENCY INACTIVATED POLIO VACCINES

American Journal of Epidemiology, 1988
In a randomized, controlled trial carried out from November 1980 to July 1983 involving 1,114 infants in Baltimore City and in Baltimore and Prince George's counties, Maryland, the serologic response to three doses of two enhanced-potency inactivated polio vaccines was compared with the response to three doses of oral polio vaccine.
A M, McBean   +4 more
openaire   +2 more sources

Trivalent Oral Polio Vaccine (Continued)

Pediatrics, 1971
I hesitate to offer the suggestion that Doctor Ghosh's disappointing results with oral polio vaccine1 may have been the result of an impotent product. Its efficacy is affected by heat, by alternate thawing and refreezing, and possibly by antiseptics and other chemicals. Before dismissing oral polio vaccination, these factors should be studied.
Milton R. Aisenson, Shanti Ghosh
openaire   +1 more source

Oral polio vaccine: fact versus fiction

Vaccine, 2004
The author of this article has now become the principal target of the accusation that HIV-1 was introduced into man through the wildcat production of an oral polio vaccine in chimpanzee cell culture more than 40 years ago in the Belgian Congo. The putative evidence presented in support of this accusation rests essentially on testimonials by local ...
openaire   +2 more sources

Trivalent Oral Polio Vaccine: Disappointing Results

Pediatrics, 1971
I was interested to read the paper on trivalent oral polio virus vaccine trials by Hardy and colleagues in your journal of March 1970,1 which reached here only recently. It prompts me to state the results we have achieved in the babies attending the Well Baby Clinic, who received three doses of trivalent oral polio vaccine at 4 to 6 weeks interval ...
openaire   +2 more sources

Molecular Analyses of Oral Polio Vaccine Samples

Science, 2001
It has been suggested that the human immunodeficiency virus (HIV), and thus the acquired immunodeficiency syndrome (AIDS) it causes, was inadvertently introduced to humans by the use of an oral polio vaccine (OPV) during a vaccination campaign launched by the Wistar Institute, Philadelphia, PA, USA, in the Belgian Congo in 1958 and 1959.
H, Poinar, M, Kuch, S, Pääbo
openaire   +2 more sources

Paralytic Disease Associated With Oral Polio Vaccines

JAMA, 1964
SINCE 1961 when the oral poliomyelitis vaccines were first made available for general use in the United States, scattered cases of paralytic disease have occurred in association with these vaccines. Many of the cases have been clinically indistinguishable from poliomyelitis.
D A, HENDERSON   +3 more
openaire   +2 more sources

The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox

Vaccine, 2010
This literature review identifies the factors that influence the decision to introduce inactivated polio vaccine (IPV) in developing countries as opposed to the policy of vaccine cessation. Attenuated viruses in the oral polio vaccine (OPV) can replicate, revert to neurovirulence and become transmissible circulating vaccine-derived polioviruses (cVDPVs)
Heinsbroek, E., Ruitenberg, E.J.
openaire   +3 more sources

Home - About - Disclaimer - Privacy